Bioxyne Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BXN.AX research report →
Price Chart
About the company
Headquartered in Sydney, Australia, Bioxyne Limited is a life sciences and health company established in 1998. The firm dedicates itself to the research, development, marketing, and distribution of nutritional supplements and beauty products. Its operations are divided into wholesale and direct sales segments, reaching customers online, through partners, and directly across the United States and Asia.
- CEO
- Samuel Watson
- IPO
- 2000
- Employees
- 16
- HQ
- Sydney, NSW, AU
Get TickerSpark's AI analysis on BXN.AX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
Latest fiscal year · YoY change
- Revenue
- $30.42M+226.3%
- Gross Profit
- $10.45M+207.5%
- Op Income
- $5.56M
- Net Income
- $4.90M+136.8%
- EPS
- $0.02+134.8%
- OCF Growth
- +276.3%
- FCF Growth
- +195.3%
- 52W High
- $1.10
- 52W Low
- $0.33
- 50D MA
- $0.84
- 200D MA
- $0.56
- Beta
- 0.65
- RSI (14)
- 44
- Avg Volume
- 402.27K
No earnings-call transcripts are available for BXN.AX yet.
- Free Float
- 17.8%
- Shares Outstanding
- 229.98M
- Float Shares
- 40.82M
Our BXN.AX coverage
Recent articles, reports, and earnings notes.
No research on BXN.AX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BXN.AX report →